<DOC>
	<DOCNO>NCT00324584</DOCNO>
	<brief_summary>The purpose study determine telecare use modern telecommunication device improve metabolic control quality life type 1 diabetic patient .</brief_summary>
	<brief_title>Web-Based Follow-Up Using Cellular Phone Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study</brief_title>
	<detailed_description>We aim compare conventional follow-up type 1 diabetic patient treat continuous subcutaneous insulin infusion ( CSII ) ( face-to-face visit ) intensive coach use Web cellular phone network data transmission Short Message Service ( SMS ) . This telecommunication device call GlucoNet . The specific objective measure efficiency GlucoNet improve metabolic control , reduce health care cost improve quality life patient .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Type 1 diabetes mellitus Age â‰¥ 18 HbA1c 7.5 10 % Treated continuous subcutaneous insulin infusion minimum 3 month Unstabilized diabetic microangiopathy Ongoing pregnancy plan pregnancy Unwilling perform minimum 4 capillary blood test per day Unable use GlucoNet device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>type 1 diabetes mellitus</keyword>
	<keyword>telecare</keyword>
	<keyword>telemedicine</keyword>
	<keyword>insulin pump therapy</keyword>
</DOC>